MIRM — MIRUM PHARMACEUTICALS INC

Ownership history in Highlander Partners, L.P.  ·  17 quarters on record

This page tracks every 13F SEC filing in which Highlander Partners, L.P. reported a position in MIRUM PHARMACEUTICALS INC (MIRM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.0% (2023 Q1)
Avg. % of fund
3.15%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 122,980 — 0% 3.49% $9.7M $78.99
2025 Q3 UNCHANGED 122,980 — 0% 3.14% $9.0M $73.31
2025 Q2 UNCHANGED 122,980 — 0% 2.40% $6.3M $50.89
2025 Q1 UNCHANGED 122,980 — 0% 3.43% $5.5M $45.05
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MIRM price (monthly, adj. close)

Other funds also holding MIRM

As of 2025 Q4 — sorted by position size

Frazier Life Sciences Management, L.P. 3Y 14.42% BOONE CAPITAL MANAGEMENT LLC 3Y 10.44% Novo Holdings A/S 3Y 7Y 7.75% Patient Square Capital LP 3Y 5.05% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.82% First Turn Management, LLC 4.35% BVF INC/IL 3Y 7Y 3.98% Rock Springs Capital Management LP 3Y 7Y 3.09% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 2.58% Atle Fund Management AB 3Y 7Y 2.26%
← Back to Highlander Partners, L.P. Holdings